Member Info for zeecoshares

.

AI overview

🚀 Combined With the Endeavour ($25M+) JV…

We now have:

✔ A copper deposit worth $800M+ NPV

AND

✔ A gold JV where a major is spending $25M+ of their own money

AND

✔ East Star retains 20% of that gold asset

AND

✔ East Star gets milestone cash payments

AND

✔ Copper porphyry targets still untouched

This is not the profile of a “high-risk penny stock.”

This is the profile of a genuinely de-risked multi-asset explorer.

Just type in east star into the search kn telegram, just jointed

When do we expect assay results?

Time will tell but I've just been taking advantage and averaging down.

Is the minor SP dropping a pull back for a rocket then? Like a sling shot?

Not finanical advice!!! IMO DYOR LOL

Average down. You bit the bullet in the first place knowing (i hope) high risk high reward. Then when goes up a bit sell the sh i t e

I have been asking the AI to interpret these rns's over some time.

Conclusion: A Poor Decision Confirmed

This update confirms the worst fears about the asset's quality. The fundamental math is now broken:

· Asset Reality: The company's primary, soon-to-be-liquidated asset is worth approximately £1 million.

· Market Fantasy: The market values the company at £9 million.

The £8 million difference is based entirely on hope in MOUs, "potential," and a management team that has been tied up in a 15-year legal battle over a parcel of largely low-value diamonds.

Investing in this company at a £9 million market cap is akin to paying £900,000 for a house that has just been appraised for £100,000, based on the hope that the seller might one day build a palace in the backyard. It is an exceptionally poor risk-reward proposition.

This tender update has moved the company from a "high-risk, speculative story" to a "high-risk, asset-poor company with a confirmed overvaluation." The risk has unequivocally increased.

Disclaimer: This is financial analysis based on public information, not financial advice. The actual tender results could differ, but the categorical breakdown provided by the company makes a dramatic upside surprise highly unlikely.

Its a dog share.

New here.

Liking what i am seeing/reading/researched

I agree rarely you get an AIM stock appearing as less risk as this!

Looking forward to the journey ahead!

Why havent vast team said what kind of diamond is in this parcel. It sounds very vague. Is it because its all gravel?

Trombone:

So the only people allowed to notice a company's repeated mistake are its CEOs? Interesting standard. I'd have thought the entire point of a discussion board was to analyze clear strategic errors.

Fkn cv..

Whimax, with all due respect, that's a misunderstanding of regulatory strategy. It's not about withholding—it's about being proactive. If you know one major agency found a weakness, you'd be incompetent not to address it preemptively for the next one. Getting the same question twice is a clear strategic failure

In my eyes just shows incompetence JUST because of the missing similar information for the EMA. Or we are ignorant to the amount of information that is being submitted and the FDA are being pedantic.

But the sp being this low won't be!

Absolutely, hit 0.5 in june, so I think even with hype this can go to at least 0.4

I was throwing the fish hook at the 25.

Make it 0.25

Which is why you're not a CEO..